Enhancing protective immunity to malaria with a highly immunogenic virus-like particle vaccine
Katharine A. Collins(Radboud University Nijmegen), Adrian V. S. Hill(Jenner Institute), Rebecca Snaith(University of Oxford), Sarah C. Gilbert(Nuffield Orthopaedic Centre), Matthew G. Cottingham(University of Oxford)
Cited by 266
Related Papers
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
|The Lancet|2020|2.6k
Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera
|Cell|2021|1.2k
Antibody evasion by the P.1 strain of SARS-CoV-2
|Cell|2021|661